Latest filing published 02 Jan 2018 for Lipocine Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Gregory Brooks Bass: trading record in brief
Gregory Brooks Bass is a declared insider of Lipocine Inc., with filings sourced from SEC (Form 4). The record holds 2 filings, all for trades on 29 December 2017.
No open-market purchase appears, only 1 sale worth €11k. Outside the open market, there are 1 option exercise. So far in 2018, the count stands at no purchases and 1 sale.
The record was last updated on 2 January 2018 with an option exercise in Lipocine Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gregory Brooks Bass
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,375 shares0Common StockSEC:0001638599-18-000030:0
- 3,750 shares@ US$3.47100.0% of flowCommon stockSEC:0001638599-18-000030:1
2 of 2 declarations